Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.67 |
| ▸ | POLB | P06746 | 1/20 | 0.66 |
| ▸ | TSHR | P16473 | 1/20 | 0.65 |
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.64 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.63 |
| ▸ | HPGD | P15428 | 3/20 | 0.60 |
| ▸ | PKM | P14618 | 2/20 | 0.60 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.58 |
| ▸ | MEN1 | O00255 | 2/20 | 0.58 |
| ▸ | NPC1 | O15118 | 2/20 | 0.58 |
| ▸ | RAB9A | P51151 | 2/20 | 0.58 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.58 |
| ▸ | GAA | P10253 | 1/20 | 0.58 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.56 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16264771 | 0.90 | TDP1 (0.65) | TDP1POLBTSHRALDH1A1KDM4E | |
| SCHEMBL17622826 | 0.90 | TDP1 (0.65) | TDP1POLBTSHRALDH1A1KDM4E | |
| SCHEMBL17622907 | 0.90 | TDP1 (0.65) | TDP1POLBTSHRALDH1A1KDM4E | |
| SCHEMBL9659018 | 0.87 | L3MBTL1 (0.65) | TDP1POLBTSHRALDH1A1KDM4E | |
| SCHEMBL17622805 | 0.86 | TDP1 (0.65) | TDP1POLBTSHRALDH1A1KDM4E | |
| SCHEMBL1514827 | 0.86 | TDP1 (0.64) | TDP1POLBALDH1A1KDM4EHPGD | |
| SCHEMBL17622908 | 0.84 | TDP1 (0.61) | TDP1POLBALDH1A1KDM4EHPGD | |
| SCHEMBL17622776 | 0.83 | TP53 (0.72) | TDP1POLBALDH1A1KDM4EHPGD | |
| SCHEMBL17622777 | 0.83 | TDP1 (0.63) | TDP1POLBALDH1A1KDM4EHPGD | |
| SCHEMBL17636349 | 0.81 | TDP1 (0.61) | TDP1POLBALDH1A1KDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3000807-B1 | MERCAPTONICOTINIC ACID COMPOUND AND PREPARATION METHOD AND USE THEREOF | ACAD OF MILITARY MEDICAL SCIENCES (CN) | 2021-04-21 | — | — | EP | disclosed |
| US-10035771-B2 | Mercaptonicotinic acid compound and preparation method and use thereof | INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, PR CHINA (CN) | 2018-07-31 | — | — | US | disclosed |
| EP-3000807-A1 | MERCAPTONICOTINIC ACID COMPOUND AND PREPARATION METHOD AND USE THEREOF | Institute of Microbiology and Epidemiology, Academy of Military Medical Sciences, PR China (CN) | 2016-03-30 | — | — | EP | disclosed |
| US-20160083347-A1 | MERCAPTONICOTINIC ACID COMPOUND AND PREPARATION METHOD AND USE THEREOF | INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY, ACADEMY OF MILITARY MEDICAL SCIENCES, PR CHINA (CN) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160083347-A1 | MERCAPTONICOTINIC ACID COMPOUND AND PREPARATION METHOD AND USE THEREOF | PREP, ENGASE, ADAMTS13 | TDP1 2036/4885POLB 3785/4885TSHR 982/4885 |
| US-10035771-B2 | Mercaptonicotinic acid compound and preparation method and use thereof | PREP, ENGASE, ADAMTS13 | TDP1 2036/4885POLB 3785/4885TSHR 982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.